成本效益-话题@MedSci

#成本效益#

74篇内容 | 2979人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1359863, encodeId=3d761359863a4, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=EUR J Cancer：卡培他滨联合贝伐单抗在转移性结直肠癌维持治疗中的成本效益分析, objectType=article, longId=125182, objectId=26791251825d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26791251825d, replyNumber=0, likeNumber=75, createdTime=2018-01-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26791251825d, moduleTitle=EUR J Cancer：卡培他滨联合贝伐单抗在转移性结直肠癌维持治疗中的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26791251825d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359862, encodeId=14e913598622f, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=EUR J Cancer：贝伐单抗治疗HER2阴性转移性乳腺癌的基于实际和试验的成本效益分析, objectType=article, longId=124994, objectId=639912499456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639912499456, replyNumber=0, likeNumber=110, createdTime=2017-12-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639912499456, moduleTitle=EUR J Cancer：贝伐单抗治疗HER2阴性转移性乳腺癌的基于实际和试验的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639912499456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359861, encodeId=4f581359861d4, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究, objectType=article, longId=124940, objectId=70251249402c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70251249402c, replyNumber=0, likeNumber=135, createdTime=2017-12-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70251249402c, moduleTitle=Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70251249402c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359860, encodeId=28571359860ed, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=BMJ：腹主动脉瘤破裂患者血管内修复与开胸修复的临床疗效和成本效益比较！, objectType=article, longId=120237, objectId=afd012023e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd012023e91, replyNumber=0, likeNumber=63, createdTime=2017-11-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd012023e91, moduleTitle=BMJ：腹主动脉瘤破裂患者血管内修复与开胸修复的临床疗效和成本效益比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd012023e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359859, encodeId=1ad51359859bb, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Gut：横向扩张大肠病变中内镜治疗的成本效益比较研究, objectType=article, longId=119878, objectId=50041198e87d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50041198e87d, replyNumber=0, likeNumber=72, createdTime=2017-11-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50041198e87d, moduleTitle=Gut：横向扩张大肠病变中内镜治疗的成本效益比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50041198e87d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359858, encodeId=c8ba1359858aa, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Celltrion选用Oracle健康科学安全解决方案帮助成本效益型救命药物和生物仿制药上市, objectType=article, longId=115673, objectId=61a61156e380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61a61156e380, replyNumber=0, likeNumber=79, createdTime=2017-10-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61a61156e380, moduleTitle=Celltrion选用Oracle健康科学安全解决方案帮助成本效益型救命药物和生物仿制药上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61a61156e380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359857, encodeId=a3b4135985e07, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Diabetic Med：社区，工作场所和个人防治糖尿病政策的成本效益, objectType=article, longId=111585, objectId=972c1115855e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=972c1115855e, replyNumber=0, likeNumber=47, createdTime=2017-09-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=972c1115855e, moduleTitle=Diabetic Med：社区，工作场所和个人防治糖尿病政策的成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=972c1115855e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359856, encodeId=5e131359856c3, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Ann Oncol：免疫检查点抑制剂对NSCLC的二线治疗的成本效益和经济影响如何？, objectType=article, longId=111168, objectId=7211111168c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7211111168c3, replyNumber=0, likeNumber=71, createdTime=2017-08-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7211111168c3, moduleTitle=Ann Oncol：免疫检查点抑制剂对NSCLC的二线治疗的成本效益和经济影响如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7211111168c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359855, encodeId=29a01359855f9, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Eur Urol：纳武单抗治疗晚期肾细胞癌的成本效益。, objectType=article, longId=109195, objectId=866d10919523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=866d10919523, replyNumber=0, likeNumber=95, createdTime=2017-08-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=866d10919523, moduleTitle=Eur Urol：纳武单抗治疗晚期肾细胞癌的成本效益。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=866d10919523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359854, encodeId=cfad1359854fe, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=JACC：替格瑞洛联合低剂量阿司匹林治疗心梗的成本效益研究, objectType=article, longId=107020, objectId=d08a10e020f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d08a10e020f8, replyNumber=0, likeNumber=48, createdTime=2017-07-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d08a10e020f8, moduleTitle=JACC：替格瑞洛联合低剂量阿司匹林治疗心梗的成本效益研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d08a10e020f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359853, encodeId=2fa3135985322, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Circulation：他汀类使用指南对冠心病和卒中初级预防的影响和成本效益评估, objectType=article, longId=105046, objectId=bce810504646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bce810504646, replyNumber=0, likeNumber=60, createdTime=2017-07-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bce810504646, moduleTitle=Circulation：他汀类使用指南对冠心病和卒中初级预防的影响和成本效益评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bce810504646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359852, encodeId=1e1a13598528b, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Arthritis Rheumatol：利妥昔单抗治疗原发性干燥综合征疲劳和口干的成本效益分析, objectType=article, longId=104131, objectId=0ebe1041310a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ebe1041310a, replyNumber=0, likeNumber=66, createdTime=2017-07-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ebe1041310a, moduleTitle=Arthritis Rheumatol：利妥昔单抗治疗原发性干燥综合征疲劳和口干的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ebe1041310a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359851, encodeId=a58d1359851b9, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Diabetic Med：Ⅱ型糖尿病预防计划的成本效益分析, objectType=article, longId=103861, objectId=778310386150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=778310386150, replyNumber=0, likeNumber=59, createdTime=2017-06-30, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=778310386150, moduleTitle=Diabetic Med：Ⅱ型糖尿病预防计划的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=778310386150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359850, encodeId=1a94135985095, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Clin Gastroenterol H：在肝移植前、后采用DAAs治疗丙型肝炎的成本效益如何？, objectType=article, longId=102355, objectId=e0fc10235501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0fc10235501, replyNumber=0, likeNumber=67, createdTime=2017-06-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0fc10235501, moduleTitle=Clin Gastroenterol H：在肝移植前、后采用DAAs治疗丙型肝炎的成本效益如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0fc10235501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359849, encodeId=074c135984934, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？, objectType=article, longId=100473, objectId=cda41004e318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda41004e318, replyNumber=0, likeNumber=116, createdTime=2017-06-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda41004e318, moduleTitle=Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda41004e318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359848, encodeId=b1db13598484a, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Hepatology：给予等待肝移植的患者口服DAAs治疗在美国是成本效益较好的治疗策略, objectType=article, longId=100376, objectId=144d1003e686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=144d1003e686, replyNumber=0, likeNumber=79, createdTime=2017-06-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=144d1003e686, moduleTitle=Hepatology：给予等待肝移植的患者口服DAAs治疗在美国是成本效益较好的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=144d1003e686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359847, encodeId=bbc2135984e3b, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Ann Intern Med：三联疗法与生物疗法治疗活动性类风湿关节炎患者的成本效益比较分析, objectType=article, longId=100184, objectId=de74100184d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de74100184d0, replyNumber=0, likeNumber=73, createdTime=2017-06-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de74100184d0, moduleTitle=Ann Intern Med：三联疗法与生物疗法治疗活动性类风湿关节炎患者的成本效益比较分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de74100184d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359846, encodeId=7a44135984638, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Crit Care：辛伐他汀治疗ARDS具有较好的成本效益, objectType=article, longId=100175, objectId=82ff1001e563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82ff1001e563, replyNumber=0, likeNumber=55, createdTime=2017-06-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82ff1001e563, moduleTitle=Crit Care：辛伐他汀治疗ARDS具有较好的成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82ff1001e563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359845, encodeId=ddd61359845f9, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=J Clin Periodontol：非手术牙周治疗对罹患II型糖尿病患者的成本效益研究, objectType=article, longId=99131, objectId=c7d5991312f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7d5991312f, replyNumber=0, likeNumber=92, createdTime=2017-05-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7d5991312f, moduleTitle=J Clin Periodontol：非手术牙周治疗对罹患II型糖尿病患者的成本效益研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7d5991312f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1359844, encodeId=0731135984464, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, objectTitle=Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？, objectType=article, longId=99007, objectId=f9689900e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9689900e21, replyNumber=0, likeNumber=0, createdTime=2017-05-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9689900e21, moduleTitle=Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9689900e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

成本效益

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

EUR J Cancer：卡培他滨联合贝伐单抗在转移性结直肠癌维持治疗中的成本效益分析

2018-01-01

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

EUR J Cancer：贝伐单抗治疗HER2阴性转移性乳腺癌的基于实际和试验的成本效益分析

2017-12-30

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究

2017-12-30

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

BMJ：腹主动脉瘤破裂患者血管内修复与开胸修复的临床疗效和成本效益比较！

2017-11-17

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Gut：横向扩张大肠病变中内镜治疗的成本效益比较研究

2017-11-15

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Celltrion选用Oracle健康科学安全解决方案帮助成本效益型救命药物和生物仿制药上市

2017-10-12

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Diabetic Med：社区，工作场所和个人防治糖尿病政策的成本效益

2017-09-02

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Ann Oncol：免疫检查点抑制剂对NSCLC的二线治疗的成本效益和经济影响如何？

2017-08-30

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Eur Urol：纳武单抗治疗晚期肾细胞癌的成本效益。

2017-08-20

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

JACC：替格瑞洛联合低剂量阿司匹林治疗心梗的成本效益研究

2017-07-30

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Circulation：他汀类使用指南对冠心病和卒中初级预防的影响和成本效益评估

2017-07-11

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Arthritis Rheumatol：利妥昔单抗治疗原发性干燥综合征疲劳和口干的成本效益分析

2017-07-02

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Diabetic Med：Ⅱ型糖尿病预防计划的成本效益分析

2017-06-30

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Clin Gastroenterol H：在肝移植前、后采用DAAs治疗丙型肝炎的成本效益如何？

2017-06-20

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？

2017-06-03

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Hepatology：给予等待肝移植的患者口服DAAs治疗在美国是成本效益较好的治疗策略

2017-06-03

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Ann Intern Med：三联疗法与生物疗法治疗活动性类风湿关节炎患者的成本效益比较分析

2017-06-01

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Crit Care：辛伐他汀治疗ARDS具有较好的成本效益

2017-06-01

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

J Clin Periodontol：非手术牙周治疗对罹患II型糖尿病患者的成本效益研究

2017-05-20

zhaojie88 (审核中...)

前往app查看评论内容

#成本效益#

Crit Care：辛伐他汀治疗急性呼吸窘迫综合征的长期结局和成本效益如何？

2017-05-19

科室
- - 订阅+
  - 更多科室
工具
服务